Veradigm (NASDAQ:MDRX) Now Covered by StockNews.com

Investment analysts at StockNews.com began coverage on shares of Veradigm (NASDAQ:MDRX) in a research note issued on Thursday. The firm set a “hold” rating on the software maker’s stock.

A number of other equities analysts also recently weighed in on MDRX. Royal Bank of Canada lowered their price target on Veradigm from $22.00 to $11.00 and set an “outperform” rating on the stock in a research report on Friday, January 19th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and issued a $10.00 price objective (down from $15.00) on shares of Veradigm in a research report on Tuesday, March 19th. Five equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $11.25.

Veradigm Price Performance

Shares of NASDAQ MDRX opened at $7.61 on Thursday. Veradigm has a 52 week low of $5.01 and a 52 week high of $14.09. The stock has a 50 day moving average price of $7.71 and a 200 day moving average price of $9.57.

Hedge Funds Weigh In On Veradigm

Several large investors have recently bought and sold shares of MDRX. Horrell Capital Management Inc. acquired a new position in shares of Veradigm during the first quarter worth $385,000. Meadow Creek Wealth Advisors LLC bought a new position in Veradigm during the 1st quarter worth $83,000. Vanguard Group Inc. lifted its holdings in Veradigm by 0.7% during the 4th quarter. Vanguard Group Inc. now owns 14,275,875 shares of the software maker’s stock worth $149,754,000 after buying an additional 95,291 shares during the period. Wellington Management Group LLP grew its position in shares of Veradigm by 117.8% in the 4th quarter. Wellington Management Group LLP now owns 5,806,297 shares of the software maker’s stock valued at $60,908,000 after buying an additional 3,140,483 shares during the last quarter. Finally, Goldman Sachs Group Inc. increased its stake in shares of Veradigm by 6.6% in the fourth quarter. Goldman Sachs Group Inc. now owns 1,596,684 shares of the software maker’s stock valued at $16,749,000 after buying an additional 99,528 shares during the period.

Veradigm Company Profile

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.